TR201716235A2 - Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim - Google Patents

Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim Download PDF

Info

Publication number
TR201716235A2
TR201716235A2 TR2017/16235A TR201716235A TR201716235A2 TR 201716235 A2 TR201716235 A2 TR 201716235A2 TR 2017/16235 A TR2017/16235 A TR 2017/16235A TR 201716235 A TR201716235 A TR 201716235A TR 201716235 A2 TR201716235 A2 TR 201716235A2
Authority
TR
Turkey
Prior art keywords
treatment
pharmaceutical composition
composition containing
active ingredients
containing multiple
Prior art date
Application number
TR2017/16235A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2017/14725A external-priority patent/TR201714725A1/tr
Priority claimed from TR2017/14893A external-priority patent/TR201714893A1/tr
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority claimed from TR2017/16209A external-priority patent/TR201716209A2/tr
Priority claimed from TR2017/16233A external-priority patent/TR201716233A2/tr
Publication of TR201716235A2 publication Critical patent/TR201716235A2/tr

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş solunum yolları hastalıklarının tedavisinde kullanılacak arformoterol ve beklometazon ile antikolinerjikler grubundan seçilen uygun bir etken maddeyi içeren farmasötik bileşimlere ilişkindir.
TR2017/16235A 2017-09-30 2017-10-20 Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim TR201716235A2 (tr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
TR2017/14725A TR201714725A1 (tr) 2017-09-30 2017-09-30 Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu
TR2017/14893A TR201714893A1 (tr) 2017-10-03 2017-10-03 Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi.
TR2017/16209A TR201716209A2 (tr) 2017-10-20 2017-10-20 Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.
TR201716217 2017-10-20
TR2017/16233A TR201716233A2 (tr) 2017-09-30 2017-10-20 Solunum yolları hastalıklarının tedavisi için birden fazla etken madde içeren farmasötik bileşim.
TR2017/16203A TR201716203A1 (tr) 2017-10-20 2017-10-20 Yeni umeklidinyum formülasyonları.

Publications (1)

Publication Number Publication Date
TR201716235A2 true TR201716235A2 (tr) 2019-04-22

Family

ID=67900837

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/16235A TR201716235A2 (tr) 2017-09-30 2017-10-20 Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim

Country Status (1)

Country Link
TR (1) TR201716235A2 (tr)

Similar Documents

Publication Publication Date Title
JOP20170135A1 (ar) مركبات ديازاسبيروألكيل مثيل-إندول
WO2015160842A8 (en) Methods and formulations of capsaicinoids and capsinoids
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
WO2015120110A3 (en) Novel pharmaceutical formulations
MX2019005009A (es) 1,2,4-triazolonas 2,4,5-trisustituidas.
MX2013003635A (es) Compuestos de n-heteroarilo.
MX2021016109A (es) Metodos y composiciones particularmente para el tratamiento del trastorno por deficit de atencion.
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
EA202090448A1 (ru) Дигидрооксадиазиноны
MX2021013139A (es) Composicion farmaceutica para la prevencion y/o tratamiento de dermatitis atopica que comprende antagonista de interleucina 31 (il-31) como ingrediente activo.
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
EA201690077A1 (ru) Терапевтически активные производные эстратриен-тиазола
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
EA201991490A1 (ru) Ароматические амиды карбоновых кислот в качестве антагонистов рецепторов брадикинина в1
EA202090666A1 (ru) Применение содержащей бензоат композиции для лечения глициновой энцефалопатии
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
ZA201906153B (en) Pharmaceutical compositions for combination therapy
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
DOP2021000069A (es) Derivados de 4 pirazin-2-ilmetil-morfolina y su uso como medicamento
EA201890929A1 (ru) Низкие дозировки композиций дипиридамола для перорального приема и их использование
TR201716235A2 (tr) Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
TR201716233A2 (tr) Solunum yolları hastalıklarının tedavisi için birden fazla etken madde içeren farmasötik bileşim.